Skip to content

13F-HR filed by Raymond James Financial Services Advisors, Inc.

Raymond James Financial Services Advisors, Inc. filed this 13F-HR for the quarter ended 2017-12-31, filed 2018-02-09, with 2,532 holding rows worth $15,993,928,000.

Accession
0001462284-18-000002
Filed
2018-02-09
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2017

A holdings report, 2,550 entries on the cover page, a total value of $15,993,928,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $15,993,928,000 with VALUE read as thousands by filing date, 13F file number 028-13494. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ACTINIUM PHARMACEUTICALS INC00507W107COM25,200$17,000thousands by filing date
Fgl Holdings Wt Expg3402m110WT11,000$17,000thousands by filing date
EGALET CORP28226B104COM16,884$17,000thousands by filing date
BLACKROCK CAPITAL INVESTMENT092533AB4NOTE 5.500prct 2/116,000$16,000thousands by filing dateprincipal
SUNTRUST BANKS INC867914103COM11,100$15,000thousands by filing datecall
M/I HOMES INC55292PAB1NOTE 3.000% 3/014,000$15,000thousands by filing dateprincipal
INVIVO THERAPEUTICS HLDGS CO46186M209COM NEW18,876$15,000thousands by filing date
Gilead Sciences,Inc.375558103COM34,000$14,000thousands by filing datecall
WMI HOLDINGS CORP92936P100COMMON16,604$14,000thousands by filing date
VERINT SYS INC92343XAA8NOTE 1.500% 6/014,000$14,000thousands by filing dateprincipal
ENCORE CAP GROUP INC292554AF9NOTE 3.000% 7/013,000$14,000thousands by filing dateprincipal
DELMAR PHARMACEUTICALS INC247078207COM NEW12,500$14,000thousands by filing date
RESOURCE CAP CORP76120WAA2NOTE 6.000prct12/014,000$14,000thousands by filing dateprincipal
PALATIN TECHNOLOGIES INC696077403COM PAR $ .0114,815$13,000thousands by filing date
SYNCHRONOSS TECHNOLOGIES INC87157BAA1NOTE 0.750 8/114,000$13,000thousands by filing dateprincipal
MONSTER DIGITAL INC COM PAR NEW61174L501Stock21,819$13,000thousands by filing date
PERSPECTIVE THERAPEUTICS INC46489V104COM30,000$12,000thousands by filing date
NAVIOS MARITIME ACQUISITIONY62159101COMMON10,403$12,000thousands by filing date
MARRONE BIO INNOVATIONS INC57165B106COM11,061$12,000thousands by filing date
RXI PHARMACEUTICALS CORP NEW74979C501COM20,433$11,000thousands by filing date
NANOVIRICIDES INC630087203COM NEW11,127$10,000thousands by filing date
AVIRAGEN THERAPEUTICS INC053761102COM16,243$9,000thousands by filing date
Procter & Gamble Co742718109COM13,500$8,000thousands by filing datecall
CURIS INC231269101COM11,060$8,000thousands by filing date
EBAY INC. COM278642103Stock12,500$7,000thousands by filing datecall
Pfizer Inc.717081103COM10,500$6,000thousands by filing datecall
SEADRILL ORDG7945E105COM24,512$6,000thousands by filing date
META PLATFORMS INC CL A30303M102COM10,600$2,000thousands by filing datecall
NIKE,Inc. Class B654106103COM35,200$2,000thousands by filing datecall
iShares Silver Trust46428Q109COM12,800$1,000thousands by filing datecall
CELGENE CORP151020104COM12,000$1,000thousands by filing datecall
COMMUNITY HEALTH SYS INC NEW203668116RIGHT 99/99/999946,294$1,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001462284-18-000002this filing2018-02-09acceptance time not in the bulk data set